Norgestimate; Ethinyl Estradiol; Folic acid
Phase 1Completed 0 watching 0 views this week๐ค Quiet
33
Development Stage
โ
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Drug Interactions
Conditions
Drug Interactions, Contraception, Pharmacokinetics
Trial Timeline
Jan 1, 2005 โ Feb 1, 2005
NCT ID
NCT00709332About Norgestimate; Ethinyl Estradiol; Folic acid
Norgestimate; Ethinyl Estradiol; Folic acid is a phase 1 stage product being developed by Johnson & Johnson for Drug Interactions. The current trial status is completed. This product is registered under clinical trial identifier NCT00709332. Target conditions include Drug Interactions, Contraception, Pharmacokinetics.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00709982 | Phase 1 | Completed |
| NCT00709332 | Phase 1 | Completed |
Competing Products
20 competing products in Drug Interactions